Thyrotoxic periodic paralysis

Mayo Clinic Proceedings

Volumn 80, Issue 1, 2005, Pages 99-105

  Lin, Shih Hua ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ELECTROLYTE; IODINE; POTASSIUM CHLORIDE; POTASSIUM ION; PROPRANOLOL; RADIOISOTOPE;

ACID BASE BALANCE; AMPLITUDE MODULATION; ATRIOVENTRICULAR BLOCK; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PH; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG PREFERENCE; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; ELECTROLYTE BALANCE; ELECTROLYTE BLOOD LEVEL; ELECTROMYOGRAPHY; FAMILY HISTORY; HEART ARRHYTHMIA; HUMAN; HYPERCALCIURIA; HYPERKALEMIA; HYPERTHYROIDISM; HYPOKALEMIA; HYPOPHOSPHATEMIA; LABORATORY TEST; LONG TERM CARE; LOW DRUG DOSE; MUSCLE ACTION POTENTIAL; MUSCLE STRENGTH; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; PATIENT CARE; PERIODIC PARALYSIS; PHOSPHATE URINE LEVEL; POTASSIUM CELL LEVEL; POTASSIUM EXCRETION; POTASSIUM TRANSPORT; POTASSIUM URINE LEVEL; QRS COMPLEX; SHORT SURVEY; SUPPLEMENTATION; SYMPTOMATOLOGY; SYSTOLIC HYPERTENSION; TACHYCARDIA; THYROIDECTOMY; THYROTOXIC PERIODIC PARALYSIS; WESTERN HEMISPHERE;

EID: 11344292860     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.1.99     Document Type: Short Survey

References (45)

1. Lin SH, Lin YF, Halperin ML. Hypokalaemia and paralysis. QJM. 2001;94:133-139.
2. McFadzean AJ, Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. BMJ. 1967;1:451-455.
3. Fisher J. Thyrotoxic periodic paralysis with ventricular fibrillation. Arch Intern Med. 1982;142:1362-1364.
4. Ober KP. Thyrotoxic periodic paralysis in the United States: report of 7 cases and review of the literature. Medicine (Baltimore). 1992;71:109-120.
5. Magsino CH Jr, Ryan AJ Jr. Thyrotoxic periodic paralysis. South Med J. 2000;93:996-1003.
6. Tran HA, Kay SE, Kende M, Doery JC, Colman PG, Read A. Thyrotoxic, hypokalaemic periodic paralysis in Australasian men. Intern Med J. 2003;33:91-94.
7. Ko GT, Chow CC, Yeung VT, Chan HH, Li JK, Cockram CS. Thyrotoxic periodic paralysis in a Chinese population. QJM. 1996;89:463-468.
8. Okinaka S, Shizume K, Iino S, et al. The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab. 1957;17:1454-1459.
9. Kelley DE, Gharib H, Kennedy FP, Duda RJ Jr, McManis PG. Thyrotoxic periodic paralysis: report of 10 cases and review of electromyographic findings. Arch Intern Med. 1989;149:2597-2600.
10. Tamai H, Tanaka K, Komaki G, et al. HLA and thyrotoxic periodic paralysis in Japanese patients. J Clin Endocrinol Metab. 1987;64:1075-1078.
11. +-ATPase activity in male rats. Neurosci Lett. 1987;78:97-100.
12. Hsu FS, Tsai WS, Chau T, Chen HH, Chen YC, Lin SH. Thyrotropin-secreting pituitary adenoma presenting as hypokalemic periodic paralysis. Am J Med Sci. 2003;325:48-50.
13. Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis [published correction appears in BMJ. 1992;304:226]. BMJ. 1991;303:1096-1099.
14. +-ATPase activity in thyrotoxic periodic paralysis. Clin Endocrinol (Oxf). 1994;41:213-216.
15. Levey GS, Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med. 1990;88:642-646.
16. 2- receptor stimulation by circulating epinephrine. N Engl J Med. 1983;309:1414-1419.
17. Ginsberg AM, Clutter WE, Shah SD, Cryer PE. Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte β-adrenergic receptor density in man. J Clin Invest. 1981;67:1785-1791.
18. Yeung RT, Tse TF. Thyrotoxic periodic paralysis: effect of propranolol. Am J Med. 1974;57:584-590.
19. Lee KO, Taylor EA, Oh VM, Cheah JS, Aw SE. Hyperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis. Lancet. 1991;337:1063-1064.
20. Gallagher EJ. Is thyrotoxic periodic paralysis a " channelopathy"? [editorial]. J Emerg Med. 1999;17:123-127.
21. v1.1) are not associated with thyrotoxic hypokalaemic periodic paralyisis. Clin Endocrinol (Oxf). 2002;56:367-375.
22. Ng WY, Lui KF, Thai AC, Cheah JS. Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. Thyroid. 2004;14:187-190.
23. Tang NL, Chow CC, Ko GT, et al. No mutation in the KCNE3 potassium channel gene in Chinese thyrotoxic hypokalaemic periodic paralysis patients. Clin Endocrinol (Oxf). 2004;61:109-112.
24. v1.1) and thyrotoxic periodic paralysis. J Clin Endocrinol Metab. 2004;89:1340-1345.
25. Goh SH. Thyrotoxic periodic paralysis: reports of seven patients presenting with weakness in an Asian emergency department. Emerg Med J. 2002;19:78-79.
26. Hsu YJ, Lin YF, Chau T, Liou JT, Kuo SW, Lin SH. Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis. Am J Med Sci. 2003;326:128-132.
27. Engel AG. Neuromuscular manifestations of Graves' disease. Mayo Clin Proc. 1972;47:919-925.
28. Guthrie GP Jr, Curtis JJ, Beilman KM. Hypophosphatemia in thyrotoxic periodic paralysis. Arch Intern Med. 1978;138:1284-1285.
29. Norris KC, Levine B, Ganesan K. Thyrotoxic periodic paralysis associated with hypokalemia and hypophosphatemia. Am J Kidney Dis. 1996;28:270-273.
30. Lin SH, Davids MR, Halperin ML. Hypokalaemia and paralysis. QJM. 2003;96:161-169.
31. Lin SH, Lin YF, Chen DT, Chu P, Hsu CW, Halperin ML. Laboratory tests to determine the cause of hypokalemia and paralysis. Arch Intern Med. 2004;164:1561-1566.
32. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am. 1990;19:35-63.
33. Lin YF, Wu CC, Pei D, Chu SJ, Lin SH. Diagnosing thyrotoxic periodic paralysis in the ED. Am J Emerg Med. 2003;21:339-342.
34. Boccalandro C, Lopez L, Boccalandro F, Lavis V. Electrocardiographic changes in thyrotoxic periodic paralysis. Am J Cardiol. 2003;91:775-777.
35. McManis PG, Lambert EH, Daube JR. The exercise test in periodic paralysis. Muscle Nerve. 1986;9:704-710.
36. Kuntzer T, Flocard F, Vial C, et al. Exercise test in muscle channelopathies and other muscle disorders. Muscle Nerve. 2000;23:1089-1094.
37. Tengan CH, Antunes AC, Gabbai AA, Manzano GM. The exercise test as a monitor of disease status in hypokalaemic periodic paralysis. J Neurol Neurosurg Psychiatry. 2004;75:497-499.
38. Engel AG, Lambert EH, Rosevear JW, Tauxe WN. Clinical and electromyographic studies in a patient with primary hypokalemic periodic paralysis. Am J Med. 1965;38:626-640.
39. Sterns RH, Cox M, Feig PU, Singer I. Internal potassium balance and the control of the plasma potassium concentration. Medicine (Baltimore). 1981;60:339-354.
40. Manoukian MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med. 1999;159:601-606.
41. Lin SH, Lu KC, Hsu YJ, Chiu JS, Hsu YD. Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis. Am J Emerg Med. In press.
42. Shayne P, Hart A. Thyrotoxic periodic paralysis terminated with intravenous propranolol. Ann Emerg Med. 1994;24:736-740.
43. Birkhahn RH, Gaeta TJ, Melniker L. Thyrotoxic periodic paralysis and intravenous propranolol in the emergency setting. J Emerg Med. 2000;18:199-202.
44. Tassone H, Moulin A, Henderson SO. The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature. J Emerg Med. 2004;26:157-161.
45. Lin SH, Lin YF. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis. 2001;37:620-623.